© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Fluconazole sprang onto the scene at a time when fungi were getting the upper hand against medical science. Back in the late 1970s and early 1980s, there were few reliable oral antifungals that could be given without difficult side effects. Doctors and patients remembered the headaches from amphotericin B—both the literal and figurative ones. Fluconazole, with its systematic name 2-(2,4-Difluorophenyl)-1,3-Bis(1H-1,2,4-Triazol-1-Yl)-2-Propanol, changed the playbook by blocking the fungal cytochrome P450 enzyme, which the fungi depend on for making their cell membranes. Researchers at Pfizer brought fluconazole forward in 1982, quickly moving it through trials. Once launched, it offered new hope for patients with systemic fungal infections and immune-compromised health, including those living with HIV/AIDS. Many doctors in infectious disease still talk about the impact this compound had during those years, managing cases where older antifungals failed or couldn’t be safely used long-term.
Fluconazole shows up in the pharmacy as round, white tablets or clear injectable liquids. It works against a range of fungal infections—from oral thrush to systemic candidiasis. The tablets usually land in doses of 50, 100, 150, or 200 mg, with the liquid forms carefully calibrated for intravenous administration, often reserved for severe cases. Unlike some antifungals, fluconazole absorbs well through the GI tract and builds effective blood levels quickly, making it easier to use for people who can’t stay in the hospital long. Patients trust it because it has a dependable safety record, and pharmacists rely on its consistent formulation and performance.
Chemically, fluconazole stands out thanks to its difluorophenyl ring paired with bis-triazole groups. At room temperature, it emerges as a white crystalline powder. It dissolves slightly in water and more readily in organic solvents like dimethyl sulfoxide or ethanol. The melting point hovers around 138-140°C, and it remains chemically stable if protected from extreme heat or moisture. Fluconazole’s molecular weight comes to about 306.3 g/mol, which keeps it small enough to move easily through biological membranes. This solubility and stability profile explains why manufacturers can blend fluconazole into tablets, capsules, and injectable compounds with ease.
Manufacturers supply fluconazole with clear labeling, focusing on its unique chemical structure and accurate dosage information. Labels highlight key technical details: precise chemical nomenclature, batch numbers, storage needs (keep at 25°C and away from direct sunlight), and expiration dates. Purity standards typically exceed 98.5%, certified with high-performance liquid chromatography. Pharmaceutical packaging meets tight sterility guidelines, especially for injectable forms. Each vial or pack receives a security seal and lot number for traceability, and printed inserts outline all relevant drug interactions and side effects because many people using fluconazole also take other medications.
The preparation of fluconazole requires a carefully controlled organic synthesis, often starting from 2,4-difluorobenzyl chloride. Chemists react this early intermediate with triazole rings, using phase transfer catalysts or other advanced reagents, usually with a solvent like acetonitrile. Process engineers drive the reaction in batch reactors, keeping close watch on pH, temperature, and stirring speed to avoid side reactions. They then isolate the product through crystallization and filtration steps, followed by drying under vacuum to achieve high-purity crystals. Quality control teams test every batch to rule out unwanted byproducts or trace contaminants. This process highlights the importance of reliable industrial chemistry and the teamwork needed to keep supply chains robust and trustworthy.
As an azole, fluconazole remains fairly resistant to chemical breakdown under normal handling. Labs have tried modifying its triazole groups and phenyl ring to broaden its antifungal power or defeat stubborn resistance, but many such tweaks alter its therapeutic window. Medicinal chemists sometimes study fluorinated analogues or derivatives with bulkier substituents, aiming to hit targets that evade parent fluconazole. Despite many attempts, few modifications have matched the original’s mix of power, safety, and ease of use. In chemical terms, it’s a tough act to follow, making it a touchstone for new research in the antifungal space.
People in the scientific world and hospital wards call fluconazole by several names. Its trade names include Diflucan, Triflucan, and Canifug, while its chemical label and invoices name it as 2-(2,4-Difluorophenyl)-1,3-Bis(1H-1,2,4-Triazol-1-Yl)-2-Propanol. Pharmacologists, on the other hand, might refer to it simply as 'FLZ' in shorthand. No matter the name, across continents and languages, doctors recognize fluconazole for what it can do: treat hard-to-reach fungal infections.
Fluconazole’s safety record stands on decades of real-world evidence. Still, health care and laboratory workers don gloves, masks, and sometimes goggles during handling to avoid inadvertent skin contact or inhalation of powder. Factories operate under strict Good Manufacturing Practices (GMP), enforcing cleanroom standards, air filtering, and frequent batch reviews. Pharmacovigilance offices regularly assess reports of liver toxicity or adverse drug reactions. The oversight helps prevent errors and supports safe, consistent products reaching clinics and pharmacies. For proper disposal, unused or expired stock gets incinerated according to environmental regulations rather than thrown away, protecting water tables and wildlife.
Fluconazole treats fungal infections in almost every organ system. It became the standard therapy for mucosal candidiasis, including esophageal and vaginal infections, and helped knock down the risk of cryptococcal meningitis among people with weakened immune systems. Neonatal intensive care teams sometimes depend on it to protect premature infants from invasive candidiasis, a leading killer in that age group. Oncologists benefit from its safety profile while treating patients on chemotherapy who are vulnerable to opportunistic infections. Its flexibility in oral and intravenous forms opens doors in both developing and resource-rich countries.
Despite its age, researchers still investigate fluconazole’s full range of action. Mycology labs continue to track resistance patterns as Candida species—and other fungi—adapt to modern prescribing practices. Emerging studies try to combine fluconazole with old and new antifungals, hoping for a synergy that can sweep up resistant strains. Industrial research teams look toward new delivery formats, such as slow-release injectables, to help keep dosing simple and effective in the field. Some groups also study its off-label effects, including use in certain autoimmune diseases or as adjunct therapy against specific cancer-related fungal complications.
While fluconazole generally avoids the harsh side effects of its predecessors, its toxicity profile needs constant vigilance. Clinical toxicologists and hepatologists have documented rare cases of liver injury, sometimes severe enough to demand stopping the drug. Providers monitor lab tests in patients on long courses, especially those with pre-existing liver problems or other risk factors. Teratogenicity echoes through medical literature too, since exposed pregnancies may face higher risks of birth defects with high-dose, long-term use. A clear-eyed approach calls for balanced decisions—using the medicine when risks outweigh the dangers of unchecked infection, and always talking patients through informed choices.
Looking down the road, fluconazole’s future sits at the intersection of resistance, accessibility, and combination therapy. Fungal infections won’t stop evolving, and resistant strains already show up in hospital labs more often than a few decades ago. Research consortia dig into the genes behind this resistance, exploring answers that might push future azole therapies further. Global health teams and NGOs lean on fluconazole for accessible, affordable antifungal coverage, especially in areas short on new drugs. Some suggest a role for fluconazole in preemptive therapy or emerging viral pandemics that threaten immune function. The story isn’t over—new studies, smarter stewardship, and a watchful eye on both patients and fungi will shape the role fluconazole plays for decades to come.
Anyone who’s ever had a persistent itchy rash or odd discomfort knows fungal infections cause more than surface annoyance. Doctors reach for fluconazole when they want a reliable attack against that kind of problem. Sold under the brand name Diflucan, fluconazole works as an antifungal—specifically, it stops fungus from growing and multiplying. This is not a medicine picked for every bug or infection, but for yeast and fungi, especially the candida group, it often lands center-stage.
Vaginal yeast infections cause pain, burning, and disrupt daily life. That’s where fluconazole steps in, taken as a single pill or sometimes in several doses. Many people deal with recurring infections, which steals time and some dignity; clinical studies show that a short course with fluconazole resolves symptoms for over 90% of patients.
Thrush, or oral candidiasis, hits hard for people with weak immune systems, asthma (due to inhaled steroids), or dentures. Fluconazole helps clear these stubborn mouth sores, especially in folks already feeling run down from illness. Doctors also use fluconazole for more serious issues, like bloodstream or deep organ infections caused by candida. These cases can turn deadly, especially in hospitals, so having a medicine that reaches into tissues and gets to work quickly means the world.
Immunocompromised patients trust fluconazole to prevent or treat infections. People going through chemotherapy, those with HIV/AIDS, organ transplant recipients, or preterm infants are vulnerable to invasive fungi. A strong antifungal acts as both armor and sword. Preventing infection here is better than treating a crisis later. Research from the CDC and WHO outlines how fluconazole helped cut rates of serious candida infections in these high-risk groups, showing real-world value well beyond what’s listed on a pharmacy leaflet.
No drug runs risk-free. Fluconazole comes with potential side effects—nausea, headaches, and rare liver problems. Taking other medications? The risk of drug interactions grows, especially with medicines for heart arrhythmias or cholesterol. Overreliance breeds drug resistance too, prompting doctors to save it for when it’s truly needed rather than every mild itch.
Seeing so many yeast infections sold short by self-diagnosis, I appreciate how medical experts stress testing before treatment. According to FDA and clinical guidelines, a “yeast infection” shouldn’t get treated over-the-counter time after time without a proper workup. Fungi adapt quicker than most realize—misusing fluconazole helps build stronger, nastier strains.
Access gaps persist among lower-income communities facing limited doctor visits or older adults with underlying illness. Good stewardship means health professionals and policy makers ensure affordable antifungals stay available, and pharmacies give clear guidance. It’s crucial to pair medicine access with honest education about symptoms, resistance, and safe use instead of hawking a single-pill fix for every spot or itch.
Taking fluconazole only after discussing symptoms with a provider protects both patient and medicine. Doctors ruling out lookalike conditions—eczema, STIs, or bacterial vaginosis—protect health and public trust. Regular follow-ups, especially with persistent symptoms or underlying immune problems, catch resistant cases early and keep people healthy. Here, science and experience push for thoughtful prescription, aiming to keep fluconazole working for years to come.
Fluconazole often comes up in conversations about treating fungal infections. Doctors hand it out for everything from stubborn yeast infections to tricky fungal problems affecting the lungs or brain. A lot of people count on it to get their health back in order. What doesn’t always get enough attention are the side effects people can run into, sometimes even after just a single dose.
Most folks tolerate fluconazole without many problems. Nausea, stomach pain, and diarrhea tend to appear most often. Sometimes, people feel a dull headache or a bad taste in their mouth. Skin rashes pop up for a few, and this is where listening to your body matters. These side effects sound mild on paper, but feeling sick to your stomach or dealing with a rash can throw off daily plans, work, and family routines.
Older adults or those on multiple medications notice these symptoms more often and sometimes react more strongly. Even with one prescription, interactions can sneak up. That’s something I’ve learned from family members who saw their energy tank after a few pills—nothing severe, but enough to question if healing was truly happening.
Liver trouble crops up in the conversation about fluconazole. Signs like yellowing skin, urine looking much darker, or feeling unexplainably tired hint at bigger problems inside the body. Doctors track liver values for good reason. People who already deal with liver or kidney challenges have even more reason to watch for signs.
Rare side effects exist—those can sound scary. Serious allergic reactions can happen: swelling, breathing trouble, or widespread hives. Every medication comes with some risk, but prompt medical attention keeps things from getting out of hand. Call it medical common sense learned from years of taking care of loved ones and filling out far too many prescription forms.
Medical studies back up the everyday complaints most patients talk about. A 2013 review in the Journal of Antimicrobial Chemotherapy found mild stomach or skin problems in as many as fifteen out of a hundred patients using fluconazole. Liver side effects stayed rare, but awareness saves lives—especially since most folks taking the drug have other health issues on their plate.
The World Health Organization and CDC keep fluconazole on their essential medicines list, but they stress doctors should weigh risks and benefits. A report from the FDA highlighted rare but real heart rhythm changes in people with underlying conditions, confirming routines should include regular checkups for those at high risk.
Playing it safe with fluconazole means telling the doctor about every medication in the cabinet, even over-the-counter pain relievers. No one likes paperwork, but a complete list cuts down on surprises. Lab work makes sense for anyone using the drug for more than a single dose.
People should not ignore odd pains, persistent nausea, or a yellow tint to their eyes. Talking about side effects might feel uncomfortable, but a phone call to the doctor can prevent bigger headaches down the road. Pharmacists also help by flagging risks and reminding people about what to watch for.
Fluconazole doesn’t show up in medicine cabinets by chance—it comes in after a diagnosis pointing toward a fungal infection. People sometimes think of fungal problems as minor, but some of them can cause real trouble, especially in people with weak immune systems. I remember my neighbor, who fought a stubborn fungal infection during chemotherapy, and it was fluconazole that the doctor pulled out as the main weapon. Fungal infections can hit hard, but taking medication in the right way helps bring quick relief and keeps the problem from coming back.
Most of the time, doctors prescribe fluconazole by mouth as tablets or liquid. Stomach upset ranks high on the list of common complaints, so having a small meal or snack with the dose helps. I’ve seen friends and family go through an entire prescription without drinking enough water—and then having headaches and dizziness. That’s avoidable. Drinking a full glass of water with each dose makes a difference.
Dosage tells the real story. A single dose sometimes clears up minor cases, like uncomplicated vaginal yeast infections. In other cases—like thrush, or ongoing nail problems—the doctor sets up a longer plan, sometimes lasting several weeks. Skipping doses or stopping early lets the infection dig in its heels, raising the risk of resistance. More stubborn fungi need more than a half-hearted approach.
Doctors give specific instructions for a reason. Everyone’s body works differently. Liver and kidney health plays a role in how well the medicine leaves your system, and a prescriber checks these before writing fluconazole up. Patients with liver problems may need extra careful monitoring and adjustments based on lab work.
Some other medications just don’t mix with fluconazole. The list is long—blood thinners like warfarin, antiseizure medications, certain diabetes drugs, and heart rhythm pills can all interact. Checking in with the pharmacy or doctor before starting helps avoid serious side effects. I’ve known people who keep an up-to-date medication list in their phone, which definitely helps at appointments.
No one likes unexpected rashes, itching, or stomach pains. For most, side effects stay mild, with headaches, nausea, or diarrhea. Yellowing of the skin or eyes, dark urine, and sudden fatigue call for a quick call to the healthcare provider. These could mean liver trouble, which needs prompt attention. Reporting side effects to a pharmacist or doctor right away helps catch serious problems early.
There’s a strong urge to stop medication once symptoms disappear. In the case of antifungals, stretching out treatment until the last prescribed dose lands leads to better outcomes. Unfinished courses create room for the infection to flare up again. I’ve seen relapses take more out of people than the original infection. Building reminders on the phone or getting support from family helps keep the plan moving forward.
Access to clear instructions and a trusted healthcare team makes navigating medications like fluconazole easier. Open conversations with the pharmacist about new symptoms or worries clear up confusion. Reading the information sheet that comes with each prescription can fill in missing details. At the end of the day, following the plan makes all the difference for people trying to shake off a tough fungal infection.
Fluconazole plays a big role in fighting off certain fungal infections, especially for folks with weak immune systems. Doctors trust it to clear up yeast infections, thrush, and other hard-hitting fungal issues. The trouble comes in when people start taking other prescriptions alongside it. Mixing drugs can turn into a risky guessing game if nobody keeps track of what’s going in or out of the body.
I’ve seen too many people surprised by side effects that never show up in the commercials. Fluconazole sticks around in the liver doing its job, but while it’s there, it slows down how fast the liver cleans out other medicines. Cholesterol drugs like atorvastatin, blood thinners like warfarin, and some antidepressants can hang around for longer than anyone intended. Fast heartbeat, muscle pain, or unexpected bruising send folks right back to the doctor because their regular dose suddenly acts much stronger.
If someone takes diabetes meds that lower blood sugar, especially sulfonylureas, it pays to be extra careful. Fluconazole can crank up their effects, sending blood sugar too low without a clear warning. The same goes for seizure meds like phenytoin. Instead of needing just a tweak in the dose, sometimes it means having to check blood levels more often, which almost nobody likes to do unless they need to.
This isn’t only about feeling dizzy or a bit off. Cardiac rhythm changes pop up as a real threat if people mix fluconazole with medicines that already raise the risk, such as certain heart meds or even some antihistamines. Doctors refer to “QT prolongation” as if everyone took high school biology. Maybe most folks don’t realize that this kind of drug interaction can flip into a heart emergency fast.
Genetics, age, liver function, and the way each person’s body handles medicine shape the risk. What comes easy for one twenty-something might floor their aging grandfather who’s taking a whole handful of pills every morning. People often forget to mention over-the-counter pills and herbal supplements, thinking natural always means safe. That’s just not true, especially with something as powerful as fluconazole.
Pharmacists do more than count pills. They see the full medicine list, catch red flags, and call the doctor if something looks off. Tech and apps help, but nothing beats telling your provider about all your medicines. It sounds simple, and yet in real life, people throw away the information leaflets without reading them. Most rely on memory, which fails easily during stress or illness.
Doctors give clear instructions when they know everything someone’s taking, but that only happens if there’s honest conversation. Blood tests don’t cost the world, and sometimes checking levels or watching closely for a week or two offers more comfort than finding out the hard way that two drugs can’t coexist happily. Non-drug approaches — cutting down on unnecessary prescriptions, using lifestyle changes when possible, and updating the med list every visit — save headaches and real harm down the line.
It all comes down to paying attention, asking questions, and refusing to be a silent passenger in your own healthcare. Fluconazole can save lives, but not at the cost of creating new problems. Information and teamwork make all the difference.
Fluconazole shows up in doctor’s offices worldwide. Fungal infections call for strong tools, and this medication sits on many prescription pads. Vaginal yeast infections, thrush, or systemic fungal issues – fluconazole targets them all. For most healthy adults, a single pill or a short course usually clears things up. Questions begin piling up when pregnancy or nursing gets added to the equation.
Fluconazole reaches the developing baby. Research shows low, single oral doses (common for yeast infections) probably don’t increase birth defect risk much. Higher or repeated doses tell a different story. Some cases describe rare but serious birth problems when mothers took larger or longer fluconazole courses, especially early in pregnancy.
Severe fungal infections during pregnancy don’t leave many safe treatment options. Some doctors choose topical medicine for milder yeast infections, which don’t move through the bloodstream in large amounts. That local approach leaves fluconazole on the back burner unless nothing else works. Usually, health workers use it only if a dangerous infection threatens the mom or baby.
Public health agencies like the CDC call for non-drug antifungal creams and ointments as the main line of defense for pregnancy. Obstetricians I work with count topical options as their standard move. If a patient used a low, one-time oral dose before realizing she was pregnant, they rarely sound alarms but will often monitor things closely.
Moms who just delivered run into infections, too. Breastfeeding women often ask about safety for their newborn. Fluconazole does slip into breastmilk in small amounts. Studies track infants exposed this way and don’t reveal clear short-term harm when mothers take standard doses. That’s reassuring, but all the facts haven’t been collected yet. Medicines sometimes roll out long-term effects later on.
Doctors balance helping mom recover fast with avoiding any surprise hits to a baby’s development. If a topical antifungal treats the infection, most lactation groups recommend those first. For deep or stubborn infections (like fungal mastitis), providers sometimes look to a short fluconazole course while keeping an eye out for baby side effects, like changes in appetite or tummy troubles.
People want more data, but studies in pregnant and breastfeeding humans always move slow. No one volunteers a volunteer parent for a risky research trial. So, experts rely on case studies, animal tests, and rare exposure frame-by-frame analysis to give advice. It’s not perfect, but pregnant and breastfeeding moms deserve real answers, honest counseling, and respect for their tough situations.
Trustworthy information gives people control. Health workers must listen, answer real fears, and provide a clear comparison of risks and benefits. It helps families make steady, informed decisions—not out of fear, but from understanding what’s known, what’s missing, and what feels safest. Sometimes “no pill” becomes the right answer; sometimes a short course changes a life for the better. Either way, the decision shapes two futures.
Instead of just avoiding questions, more clear medical reporting and honest communication help everyone. Ongoing research, especially registry programs that follow real families, could turn today’s gray areas into tomorrow’s guidance. Mothers should expect choices explained in plain language by a trusted professional, not half-hearted guesses or cold refusals.
| Names | |
| Preferred IUPAC name | 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol |
| Other names |
Diflucan Trican Canozol Forcan Zocon |
| Pronunciation | /fluːˈkɒn.ə.zəʊl/ |
| Identifiers | |
| CAS Number | 86386-73-4 |
| 3D model (JSmol) | `3D model (JSmol)` string for Fluconazole: ``` C1=CN=CN1CC(C2=C(F)C=CC(F)=C2)(CO)N3C=NC=N3 ``` |
| Beilstein Reference | 5089410 |
| ChEBI | CHEBI:4607 |
| ChEMBL | CHEMBL479 |
| ChemSpider | 58538 |
| DrugBank | DB00196 |
| ECHA InfoCard | 03e6c7a7-172c-4230-bfc8-d617fa5fac75 |
| EC Number | EC 620-315-4 |
| Gmelin Reference | 107055 |
| KEGG | D00351 |
| MeSH | D004976 |
| PubChem CID | 3365 |
| RTECS number | TX4097750 |
| UNII | 8VZV102JFY |
| UN number | UN number: Not assigned |
| CompTox Dashboard (EPA) | DTXSID4020777 |
| Properties | |
| Chemical formula | C13H12F2N6O |
| Molar mass | 306.2 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 0.413 g/cm3 |
| Solubility in water | 0.01 mg/mL |
| log P | 0.5 |
| Vapor pressure | Negligible |
| Acidity (pKa) | pKa = 1.76 |
| Basicity (pKb) | 1.7 |
| Magnetic susceptibility (χ) | -1.2e-6 cm³/mol |
| Dipole moment | 2.72 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 475.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -4711 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | J02AC01 |
| Hazards | |
| Main hazards | Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07 |
| Pictograms | GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry place. Avoid contact with skin, eyes, and clothing. Wash thoroughly after handling. Use only with adequate ventilation. Do not breathe dust or vapour. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | > 198.3°C |
| Lethal dose or concentration | LD50 (rat, oral): 1271 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Fluconazole (Invoice Name: 2-(2,4-Difluorophenyl)-1,3-Bis(1H-1,2,4-Triazol-1-Yl)-2-Propanol) is "1271 mg/kg (oral, rat) |
| REL (Recommended) | 0.2 mg/m³ |
| IDLH (Immediate danger) | Not Listed |
| Related compounds | |
| Related compounds |
Ketoconazole Itraconazole Voriconazole Posaconazole Clotrimazole Miconazole Efinaconazole Isavuconazole Terconazole |
